The presence of non-hepatic malignancy and its implication in pursuing liver transplantation Review


Authors: Chayanupatkul, M.; Gambarin-Gelwan, M.; Schiano, T. D.
Review Title: The presence of non-hepatic malignancy and its implication in pursuing liver transplantation
Abstract: Background: Primary extrahepatic malignancy and chronic liver disease co-exist in a considerable number of patients, creating a dilemma both in the aspects of liver transplant candidacy and cancer therapy. In this review, we will explore several aspects and controversies of liver transplantation in patients with non-hepatocellular carcinoma malignancy including risks of cancer recurrence after liver transplantation and the ethical dilemma of the selection of liver transplantation candidates with non-hepatic malignancy. Methods: We performed a search in several online databases and reviewed published articles and ongoing clinical trials in the topics of transplantation and pre-existing malignancies. Results and Discussion: Liver transplantation can be safely performed in selected patients with pre-existing extrahepatic malignancies with low recurrence rate if they have an expected 5-year survival rate of at least 50%. The cancer-free period before transplantation depends on the type, stage, and location of cancer. A shorter or no wait-time may be considered in an early stage cancer or carcinoma in situ. The urgency and benefits of liver transplantation should also be taken into consideration when determining a reasonable wait-time. This is particularly important in patients with decompensated cirrhosis who cannot afford to wait a few years before they can undergo liver transplantation. © 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Keywords: liver transplantation; chemotherapy; neoplasm; outcome; malignancy
Journal Title: Clinical Transplantation
Volume: 35
Issue: 10
ISSN: 0902-0063
Publisher: Wiley Blackwell  
Date Published: 2021-10-01
Start Page: e14410
Language: English
DOI: 10.1111/ctr.14410
PUBMED: 34189778
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 1 December 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors